4.5 Article

Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis

期刊

CANCER BIOLOGY & THERAPY
卷 9, 期 10, 页码 832-840

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.9.10.11589

关键词

apoptosis; BAG-1; lung cancer; siRNA

类别

资金

  1. National Natural Science Foundation of China [30500221, 30500496]
  2. Science and Technology Support Key Program of Tianjin [09ZCZDSF04100]
  3. National Ministry of Science of China [2006DFB32330]

向作者/读者索取更多资源

BAG-1 is a multifunctional protein that interacts with a wide range of target molecules to regulate apoptosis. However, the exact mechanism by which BAG-1 inhibits apoptosis is unknown. In the current study, we comprehensively investigate BAG-1 mediated changes in gene expression by comparing the gene expression profile after BAG-1 siRNA silencing in the human lung adenocarcinoma cell line A549. Microarray assay revealed that expression of 589 genes was altered, including 177 upregulated and 412 downregulated genes. Real-time PCR assay of the changes in gene expression indicated a concordance of 86.48% (64/74) with that observed by microarray. The upregulated genes included EGFR, Jun, HSPA1A and CASP 7; while the downregulated genes included Lyn, HRAS and TGF alpha. Furthermore, we confirmed by western blot that the expression of EGFR, Jun and HSPA1A were significantly increased, while expression of Lyn and HRAS were dramatically decreased after BAG-1 gene silencing. After transfection with BAG-1 siRNA, lung cancer cell lines A549 and L9981 exhibited significantly enhanced sensitivity to cisplatin-induced apoptosis. Thus, silencing of the BAG-1 gene resulted in changes in expression of apoptosis-related genes and sensitized A549 and L9981 cells to cisplatin-induced apoptosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene

Yongwen Li, Hongbing Zhang, Ying Li, Chenlong Zhao, Yaguang Fan, Jinghao Liu, Xin Li, Hongyu Liu, Jun Chen

MOLECULAR CARCINOGENESIS (2018)

Article Oncology

Activating transcription factor 3 promotes malignance of lung cancer cells in vitro

Xuebing Li, Xuexia Zhou, Yongwen Li, Lingling Zu, Hongli Pan, Boning Liu, Wang Shen, Yaguang Fan, Qinghua Zhou

THORACIC CANCER (2017)

Article Oncology

MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer

Yongwen Li, Hongbing Zhang, Yunlong Dong, Yaguang Fan, Ying Li, Chenlong Zhao, Cong Wang, Jinghao Liu, Xin Li, Ming Dong, Hongyu Liu, Jun Chen

JOURNAL OF CANCER (2017)

Article Oncology

miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene

Yongwen Li, Hongbing Zhang, Hao Gong, Yin Yuan, Ying Li, Cong Wang, Weiting Li, Zihe Zhang, Minghui Liu, Hongyu Liu, Jun Chen

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Chemistry, Multidisciplinary

HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population

Cong Wang, Ying Li, Yong-wen Li, Hong-bing Zhang, Hao Gong, Yin Yuan, Wei-ting Li, Hong-yu Liu, Jun Chen

ACTA PHARMACOLOGICA SINICA (2018)

Article Oncology

HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer

Minghui Liu, Hongyi Zhang, Ying Li, Rui Wang, Yongwen Li, Hongbing Zhang, Dian Ren, Hongyu Liu, Chunsheng Kang, Jun Chen

CANCER SCIENCE (2018)

Article Biotechnology & Applied Microbiology

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer

Orgilmaa Regzedmaa, Ying Li, Yongwen Li, Hongbing Zhang, Jin Wang, Hao Gong, Yin Yuan, Weiting Li, Hongyu Liu, Jun Chen

ONCOTARGETS AND THERAPY (2019)

Article Biology

Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

Ling Cai, Hongyu Liu, Fang Huang, Junya Fujimoto, Luc Girard, Jun Chen, Yongwen Li, Yu-An Zhang, Dhruba Deb, Victor Stastny, Karine Pozo, Christin S. Kuo, Gaoxiang Jia, Chendong Yang, Wei Zou, Adeeb Alomar, Kenneth Huffman, Mahboubeh Papari-Zareei, Lin Yang, Benjamin Drapkin, Esra A. Akbay, David S. Shames, Ignacio I. Wistuba, Tao Wang, Jane E. Johnson, Guanghua Xiao, Ralph J. DeBerardinis, John D. Minna, Yang Xie, Adi F. Gazdar

Summary: This study revealed the connection between immune phenotypes and NE scores, as well as the differences in immune gene expression between classic SCLC and variant SCLC. The research demonstrated the re-expression of MHC I in SCLC upon development of chemoresistance. These findings provide guidance for the design of treatment regimens in SCLC.

COMMUNICATIONS BIOLOGY (2021)

Letter Oncology

Lung microbiota: Unexploited treasure hidden in the immune microenvironment of lung cancer

Ruifeng Shi, Yongwen Li, Hongyu Liu, Jun Chen

THORACIC CANCER (2021)

Article Respiratory System

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

Ying Li, Yongwen Li, Hongbing Zhang, Ruifeng Shi, Zihe Zhang, Hongyu Liu, Jun Chen

Summary: The study revealed that aberrant expression of EML4-ALK leads to activation of the JAK2-STAT signaling pathway, essential for the development of non-small cell lung cancer. Inhibiting EML4-ALK resulted in increased apoptosis in lung cancer cells, while overexpression of EML4-ALK increased cell viability. Additionally, treatment with ALK or JAK-STAT pathway inhibitors significantly decreased cell viability in EML4-ALK-positive lung cancer cells.

BMC PULMONARY MEDICINE (2021)

Article Oncology

Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis

Yongwen Li, Ruifeng Shi, Guangsheng Zhu, Chen Chen, Hua Huang, Min Gao, Songlin Xu, Peijun Cao, Zihe Zhang, Di Wu, Xuanguang Li, Hongyu Liu, Jun Chen

Summary: Patients with advanced stages of NSCLC have poor 5-year survival rates, highlighting the urgent need for novel biomarkers. The study identified hsa_circ_0043256 as a potential therapeutic target for lung cancer and constructed a circRNA-miRNA-mRNA regulatory network.

THORACIC CANCER (2022)

Article Biochemistry & Molecular Biology

Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells

Zhenhua Pan, Meidi Zhang, Fengyu Zhang, Hongli Pan, Yongwen Li, Yi Shao, Xin Yuan, Ju Wang, Jun Chen

Summary: This study identified the role of lung adenocarcinoma cancer stem cells (LCSCs) in the progression, metastasis, therapy resistance, and recurrence of lung cancer. LCSCs showed high survival rates and increased expression of the stemness marker CD44. Single-cell RNA sequencing revealed heterogeneous subpopulations of LCSCs with different degrees of differentiation and identified key factors associated with cell dedifferentiation and increased CD44 expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biotechnology & Applied Microbiology

Exploring the Association Between PRC2 Genes Variants and Lung Cancer Risk in Chinese Han Population

Min Gao, Yongwen Li, Hua Huang, Yaguang Fan, Ruifeng Shi, Lianchun Su, Chen Chen, Xuanguang Li, Guangsheng Zhu, Di Wu, Peijun Cao, Hongyu Liu, Jun Chen, Shirong Kang

Summary: This study demonstrates that genetic variants in PRC2 genes, including rs17171119T>G, rs10898459 T>C, and rs1136258 C>T, are associated with a decreased risk of developing lung cancer.

ONCOTARGETS AND THERAPY (2023)

Article Biotechnology & Applied Microbiology

Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication

Guanghui Xie, Yongwen Li, Yongjun Jiang, Xian Ye, Jianfeng Tang, Jun Chen

Summary: HIPPI is highly expressed in NSCLC tissues and its RNA interference inhibits NSCLC cell proliferation and tumor growth, attenuates cell migration and invasion, and enhances sensitivity to cisplatin. HIPPI positively regulates key regulators of DNA replication, MCM2, MCM6, and MCM8, highlighting its importance in NSCLC tumor biology.

ONCOTARGETS AND THERAPY (2021)

暂无数据